Phoenix Wealth Advisors Editas Medicine, Inc. Transaction History

Phoenix Wealth Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$31.29 - $56.64 $274,820 - $497,469	-8,783 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$39.71 - $90.58 $107,296 - $244,747	-2,702 Reduced 23.53%	8,783 $376,000
Q4 2020 Feb 05, 2021	BUY	$27.07 - $84.35 $310,898 - $968,759	11,485 New	11,485 $805,000

247

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $168M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.